Nanjing Medlander Medical Technology Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Nanjing Medlander Medical Technology Co., Ltd.

Why is Nanjing Medlander Medical Technology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of 9.11% and Operating profit at -0.38% over the last 5 years

Negative results in Sep 25

INTEREST(HY) At CNY 0.76 MM has Grown at 31.68%
DEBT-EQUITY RATIO (HY) Highest at -56.87 %

With ROE of 7.21%, it has a attractive valuation with a 2.87 Price to Book Value

Over the past year, while the stock has generated a return of 68.46%, its profits have risen by 27% ; the PEG ratio of the company is 1.5

Market Beating Performance

The stock has generated a return of 68.46% in the last 1 year, much higher than market (China Shanghai Composite) returns of 22.49%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Medlander Medical Technology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Nanjing Medlander Medical Technology Co., Ltd.

-100.0%

1.73

63.27%

China Shanghai Composite

16.78%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

8.51%

EBIT Growth (5y)

-14.69%

EBIT to Interest (avg)

72.17

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.61

Sales to Capital Employed (avg)

0.29

Tax Ratio

12.71%

Dividend Payout Ratio

77.95%

Pledged Shares

Institutional Holding

ROCE (avg)

29.08%

ROE (avg)

7.41%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.76

EV to EBIT

5.33

EV to EBITDA

3.65

EV to Capital Employed

0.46

EV to Sales

0.68

PEG Ratio

Dividend Yield

ROCE (Latest)

8.58%

ROE (Latest)

6.09%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by 0.08% (YoY

-24What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at CNY 103.18 MM

INTEREST(HY)

At CNY 0.64 MM has Grown at 9.54%

ROCE(HY)

Lowest at 6.3%

DEBT-EQUITY RATIO (HY)

Highest at -54.91 %

NET SALES(Q)

At CNY 99.2 MM has Fallen at -16.13%

PRE-TAX PROFIT(Q)

At CNY 24.21 MM has Fallen at -44.04%

NET PROFIT(Q)

At CNY 22.59 MM has Fallen at -42.49%

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.01 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 12.57 times

Here's what is working for Nanjing Medlander Medical Technology Co., Ltd.

Raw Material Cost

Fallen by 0.08% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Medlander Medical Technology Co., Ltd.

Operating Cash Flow

Lowest at CNY 103.18 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

At CNY 99.2 MM has Fallen at -16.13%

Year on Year (YoY)

MOJO Watch

Near term sales trend is very negative

Net Sales (CNY MM)

Pre-Tax Profit

At CNY 24.21 MM has Fallen at -44.04%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 22.59 MM has Fallen at -42.49%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest

At CNY 0.64 MM has Grown at 9.54%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -54.91 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 2.01 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 12.57 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio